Basic Stats
| CIK | 1478455 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Many Bright Ideas Technologies Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| February 2, 2012 |
Registration Withdrawal Med BioGene Inc. 701 West Georgia Street, Suite 1500 Vancouver, British Columbia V7Y 1C6 Canada February 2, 2012 Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Re: Med BioGene Inc. File No. 333-164050 Application for Withdrawal on Form RW pursuant to Rule 477 of the Securities Act of 1933 of the Registration Statem |
|
| June 22, 2010 |
EXHIBIT 10.9 WAIVER AND ACKNOWLEDGEMENT May 27, 2010 WHEREAS: A. Reference is made to the following agreements dated effective February 24, 2009 between University Health Network (?UHN?) and Med BioGene Inc. (?MBI?): (i) Additional Exclusive License Agreement; (ii) Additional Sponsored Research Agreement (?Additional Research Agreement?); (iii) Amended and Restated Exclusive License Agreement; and |
|
| June 22, 2010 |
As filed with the Securities and Exchange Commission on June 22, 2010 As filed with the Securities and Exchange Commission on June 22, 2010 Registration No. |
|
| June 22, 2010 |
Form 8-A/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A Amendment No. 1 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Med BioGene Inc. (Exact name of registrant specified in its charter) British Columbia Not Applicable (State or other jurisdiction of incorporation) (I.R.S. Employer Ide |
|
| June 18, 2010 |
Form 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Med BioGene Inc. (Exact name of registrant specified in its charter) British Columbia Not Applicable (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) 300 |
|
| June 9, 2010 |
EXHIBIT 10.10 WAIVER AND ACKNOWLEDGEMENT May 27, 2010 WHEREAS: A. Reference is made to the following agreements dated effective February 24, 2009 between University Health Network (?UHN?) and Med BioGene Inc. (?MBI?): (i) Additional Exclusive License Agreement; (ii) Additional Sponsored Research Agreement (?Additional Research Agreement?); (iii) Amended and Restated Exclusive License Agreement; an |
|
| June 9, 2010 |
As filed with the Securities and Exchange Commission on June 9, 2010 Amendment no. 7 to Form F-1 Table of Contents As filed with the Securities and Exchange Commission on June 9, 2010 Registration No. 333-164050 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 7 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Med BioGene Inc. (Exact name of Registrant as specified in its charter) British Columbia 8071 Not App |
|
| May 27, 2010 |
AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT EX-10.9 5 dex109.htm AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT EXHIBIT 10.9 AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT This amended and restated agreement (this “Agreement”) is made effective as of the 14th day of April 2008 (the “Effective Date”) and is amended as of the 24th day of February 2009 (the “Amendment Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incor |
|
| May 27, 2010 |
ADDITIONAL SPONSORED RESEARCH AGREEMENT EX-10.7 4 dex107.htm ADDITIONAL SPONSORED RESEARCH AGREEMENT EXHIBIT 10.7 ADDITIONAL SPONSORED RESEARCH AGREEMENT This agreement (this “Agreement”) is made effective as of the 24th day of February 2009 (the “Effective Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997, having a principal office at 190 Eliza |
|
| May 27, 2010 |
As filed with the Securities and Exchange Commission on May 27, 2010 F-1/A 1 df1a.htm AMENDMENT NO. 6 TO FORM F-1 Table of Contents As filed with the Securities and Exchange Commission on May 27, 2010 Registration No. 333-164050 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 6 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Med BioGene Inc. (Exact name of Registrant as specified in its charter) British Colu |
|
| May 7, 2010 |
Exhibit 1.1 Underwriting Agreement May , 2010 Rodman & Renshaw, LLC As representative of the several Underwriters named in Schedule I hereto c/o Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor New York, New York 10020 Ladies and Gentlemen: Med BioGene Inc., a corporation existing under the laws of the Province of British Columbia (?Company?), confirms its agreement, subject to the te |
|
| May 7, 2010 |
As filed with the Securities and Exchange Commission on May 7, 2010 Amendment No. 5 to Form F-1 Table of Contents As filed with the Securities and Exchange Commission on May 7, 2010 Registration No. 333-164050 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 5 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Med BioGene Inc. (Exact name of Registrant as specified in its charter) British Columbia 8071 Not Appl |
|
| April 23, 2010 |
As filed with the Securities and Exchange Commission on April 23, 2010 Table of Contents As filed with the Securities and Exchange Commission on April 23, 2010 Registration No. |
|
| April 23, 2010 |
Exhibit 1.1 Underwriting Agreement May , 2010 Rodman & Renshaw, LLC As representative of the several Underwriters named in Schedule I hereto c/o Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor New York, New York 10020 Ladies and Gentlemen: Med BioGene Inc., a corporation existing under the laws of the Province of British Columbia (?Company?), confirms its agreement, subject to the te |
|
| April 23, 2010 |
Consent of Hayden Bergman Rooney, Professional Corporation Consent of Hayden Bergman Rooney, Professional Corporation. Exhibit 5.3 Consent of Hayden Bergman Rooney, Professional Corporation We hereby consent to the reference to our opinions in the section “United States Federal Income Tax Information for United States Residents” in the Registration Statement on Form F-1 of Med BioGene Inc. filed on December 28, 2009, as amended. In addition, we hereby con |
|
| April 13, 2010 |
As filed with the Securities and Exchange Commission on April 12, 2010 Amendment No. 3 to Form F-1 Table of Contents As filed with the Securities and Exchange Commission on April 12, 2010 Registration No. 333-164050 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 3 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Med BioGene Inc. (Exact name of Registrant as specified in its charter) British Columbia 8071 Not A |
|
| April 13, 2010 |
Exhibit 1.1 Underwriting Agreement May , 2010 Rodman & Renshaw, LLC As representative of the several Underwriters named in Schedule I hereto c/o Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor New York, New York 10020 Ladies and Gentlemen: Med BioGene Inc., a corporation existing under the laws of the Province of British Columbia (“Company”), confirms its agreement, subject to the te |
|
| March 19, 2010 |
As filed with the Securities and Exchange Commission on March 19, 2010 Table of Contents As filed with the Securities and Exchange Commission on March 19, 2010 Registration No. |
|
| March 19, 2010 |
AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT EXHIBIT 10.9 AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT This amended and restated agreement (this “Agreement”) is made effective as of the 14th day of April 2008 (the “Effective Date”) and is amended as of the 24th day of February 2009 (the “Amendment Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 199 |
|
| March 19, 2010 |
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT EXHIBIT 10.8 AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT This amended and restated agreement (this “Agreement”) is made effective as of the 14th day of April 2008 (the “Effective Date”) and is amended as of the 24th day of February 2009 (the “Amendment Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997 |
|
| March 19, 2010 |
Insert name and address of transferee Specimen of Registrant's Common Share Certificate Exhibit 4.1 A BRITISH COLUMBIA BUSINESS CORPORATIONS ACT COMPANY SEE REVERSE FOR CERTAIN DEFINITIONS in the Authorized share structure of the above named Company subject to the Articles of the Company transferable on the Central Securities Register of the Company by the registered holder in person or by attorney duly authorized in writing upon surr |
|
| March 19, 2010 |
ADDITIONAL EXCLUSIVE LICENSE AGREEMENT EXHIBIT 10.6 ADDITIONAL EXCLUSIVE LICENSE AGREEMENT This agreement (this “Agreement”) is made effective as of the 24th day of February 2009 (the ”Effective Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997, having a principal office at 190 Elizabeth Street, R. Fraser Elliott Building – Room 1S-417, Toronto |
|
| March 19, 2010 |
EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL January 12, 2009 Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL January 12, 2009 David G. Matthews 5650 Eagle Court North Vancouver, British Columbia V7R 4V4 Dear Dave: Re: Terms of Employment with Med BioGene Inc. (the “Company”) This Agreement confirms the terms and conditions of your employment by the Company and will constitute your employment agreement. Those terms and c |
|
| March 19, 2010 |
ADDITIONAL SPONSORED RESEARCH AGREEMENT EXHIBIT 10.7 ADDITIONAL SPONSORED RESEARCH AGREEMENT This agreement (this “Agreement”) is made effective as of the 24th day of February 2009 (the “Effective Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997, having a principal office at 190 Elizabeth Street, R. Fraser Elliott Building - Room 1S-417, Toront |
|
| February 16, 2010 |
MED BIOGENE INC. (the “Company”) Exhibit 3.2 MED BIOGENE INC. (the ?Company?) The Company has amended its articles and has as its articles the following: Full name and signature of a director Date of signing /s/ ERINN B. BROSHKO February 12, 2010 Incorporation number: MED BIOGENE INC. (the ?Company?) ARTICLES 1. INTERPRETATION 1 1.1 Definitions 1 1.2 Business Corporations Act and Interpretation Act Definitions Applicable 1 2. SHA |
|
| February 16, 2010 |
EXHIBIT 4.10 FORM 2F CPC ESCROW AGREEMENT THIS AGREEMENT is made as of the 6th day of February, 2007 AMONG: Corporation Capital SEP, a corporation incorporated under the Canada Business Corporations Act, having its principal place of business at 500, Grande Allée East, Suite 200, in the city of Quebec, Province of Quebec, represented by its President, Stéphane Bergeron, and by its Secretary, Mtre |
|
| February 16, 2010 |
As filed with the Securities and Exchange Commission on February 16, 2010 Table of Contents As filed with the Securities and Exchange Commission on February 16, 2010 Registration No. |
|
| February 16, 2010 |
EXHIBIT 4.2 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE , 2007. WITHOUT PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE (“TSXV”) AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF T |
|
| February 16, 2010 |
EX-4.11 8 dex411.htm SHAREHOLDERS RIGHTS PLAN AGREEMENT Exhibit 4.11 MED BIOGENE INC. SHAREHOLDER RIGHTS PLAN AGREEMENT dated as of January 15, 2010 between Med BioGene Inc. and Computershare Investor Services Inc. As Rights Agent MED BIOGENE SHAREHOLDER RIGHTS PLAN Table of Contents Page ARTICLE 1 - INTERPRETATION 2 1.1 Definitions 2 1.2 Currency 17 1.3 Grandfather Provision 17 1.4 Holder 17 1.5 |
|
| February 16, 2010 |
MED BIOGENE INC. UNDERWRITER’S WARRANT [ ] Common Shares , 2010 EX-4.8 5 dex48.htm FORM OF WARRANT TO BE GRANTED TO THE UNDERWRITER Exhibit 4.8 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF SUCH SECURITIES BY ANY PERSON FOR A PERIOD OF SIX |
|
| February 16, 2010 |
EXHIBIT 4.9 FORM 2F CPC ESCROW AGREEMENT THIS AGREEMENT is made as of the 31st day of August, 2007 AMONG: Berkeley Capital Corp. II (the Issuer) AND: Equity Transfer & Trust Company (the Escrow Agent) AND: EACH OF THE UNDERSIGNED SECURITYHOLDERS OF THE ISSUER (a Securityholder or you) (collectively, the Parties) This Agreement is being entered into by the Parties under Exchange Policy 2.4 - Capita |
|
| February 16, 2010 |
Notice of Articles BUSINESS CORPORATIONS ACT Exhibit 3.1 Date and Time: February 16, 2010 11:38 AM Pacific Time Ministry of Finance BC Registry Services Mailing Address: PO BOX 9431 Stn Prov Govt. Victoria BC V8W 9V3 www.corporateonline.gov.bc.ca Location: 2nd Floor - 940 Blanshard St. Victoria BC 250 356-8626 Notice of Articles BUSINESS CORPORATIONS ACT This Notice of Articles was issued by the Registrar on: February 16, 2010 11:35 AM Pacif |
|
| December 28, 2009 |
Re: Offer of Board Seat and Engagement of Consulting Services Exhibit 10.5 May 27, 2008 PRIVATE AND CONFIDENTIAL BY HAND Dr. Heiner Dreismann 4253 Golden Oak Ct Danville, CA 94506 Dear Heiner: Re: Offer of Board Seat and Engagement of Consulting Services It has been a pleasure to speak with you over these last few weeks and to hear your insight into the molecular diagnostics industry. Med BioGene (“MBI”), being an early-stage molecular diagnostic company, wo |
|
| December 28, 2009 |
Subsidiaries of Med BioGene Inc. Exhibit 21.1 Subsidiaries of Med BioGene Inc. DTX Acquisition Company Inc. |
|
| December 28, 2009 |
AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT Exhibit 10.9 AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT This amended and restated agreement (this ?Agreement?) is made effective as of the 14th day of April 2008 (the ?Effective Date?) and is amended as of the 24th day of February 2009 (the ?Amendment Date?) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 199 |
|
| December 28, 2009 |
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT Exhibit 10.8 AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT This amended and restated agreement (this “Agreement”) is made effective as of the 14th day of April 2008 (the “Effective Date”) and is amended as of the 24th day of February 2009 (the “Amendment Date”) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997 |
|
| December 28, 2009 |
Exhibit 10.1 FORM OF INDEMNITY AGREEMENT THIS AGREEMENT is entered into effective the day of , BETWEEN: MED BIOGENE INC., a company incorporated under the laws of British Columbia, and having its address at #300 - 2386 East Mall, Gerald McGavin Building, Vancouver, British Columbia V6T 1Z3. (the “Company”) AND: (the “Indemnitee”) WHEREAS, the Indemnitee has agreed to serve, at the request of the C |
|
| December 28, 2009 |
Notice of Articles BUSINESS CORPORATIONS ACT Exhibit 3.1 Date and Time: November 25, 2009 03:33 PM Pacific Time Ministry of Finance BC Registry Services Mailing Address: PO BOX 9431 Stn Prov Govt. Victoria BC V8W 9V3 www.corporateonline.gov.bc.ca Location: 2nd Floor - 940 Blanshard St. Victoria BC 250 356-8626 Notice of Articles BUSINESS CORPORATIONS ACT This Notice of Articles was issued by the Registrar on: July 13, 2009 09:57 AM Pacific T |
|
| December 28, 2009 |
MED BIOGENE INC. MED BIOGENE INC. 2006 INCENTIVE STOCK OPTION PLAN Exhibit 10.2 MED BIOGENE INC. MED BIOGENE INC. 2006 INCENTIVE STOCK OPTION PLAN 1. PURPOSE OF THE PLAN 1.1 Purpose of this Plan. The purpose of this Plan is to promote the interests of MBI by: (a) furnishing certain directors, officers, employees or consultants of MBI or an Affiliate or other persons as the Compensation Committee may approve with greater incentive to further develop and promote th |
|
| December 28, 2009 |
EXHIBIT 4.7 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE APRIL 25, 2010. WITHOUT PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE (?TSXV?) AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILIT |
|
| December 28, 2009 |
MED BIOGENE INC. (the “Company”) EX-3.2 3 dex32.htm ARTICLES OF REGISTRANT Exhibit 3.2 MED BIOGENE INC. (the “Company”) The Company has as its articles the following articles. Full name and signature of first director Date of signing /s/ THILLAINATHAN YOGANATHAN April 28, 2006 Incorporation number: MED BIOGENE INC. (the “Company”) ARTICLES 1. INTERPRETATION 1 1.1 Definitions 1 1.2 Business Corporations Act and Interpretation Act |
|
| December 28, 2009 |
AGENT’S COMPENSATION OPTION AGREEMENT EXHIBIT 4.3 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE , 2007. WITHOUT PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE (?TSXV?) AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF T |
|
| December 28, 2009 |
MED BIOGENE INC. UNDERWRITER’S WARRANT [ ] Common Shares , 2010 Exhibit 4.8 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF SUCH SECURITIES BY ANY PERSON FOR A PERIOD OF SIX (6) MONTHS IMMEDIATELY FOLLOWING THE DATE OF EFFECTIVENESS OF THE CO |
|
| December 28, 2009 |
EXHIBIT 4.2 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE , 2007. WITHOUT PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE (“TSXV”) AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF T |
|
| December 28, 2009 |
ADDITIONAL EXCLUSIVE LICENSE AGREEMENT Additional Exclusive License Agreement Registrant and University Health Network Exhibit 10. |
|
| December 28, 2009 |
EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL January 12, 2009 Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL January 12, 2009 David G. Matthews 5650 Eagle Court North Vancouver, British Columbia V7R 4V4 Dear Dave: Re: Terms of Employment with Med BioGene Inc. (the “Company”) This Agreement confirms the terms and conditions of your employment by the Company and will constitute your employment agreement. Those terms and c |
|
| December 28, 2009 |
EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL May 12, 2006 Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT MED BIOGENE INC. PRIVATE AND CONFIDENTIAL May 12, 2006 Erinn B. Broshko 102-2119 Yew Street Vancouver, British Columbia V6K 3G6 Dear Mr. Broshko: Re: Terms of Employment with Med BioGene Inc. (the ?Company?) This Agreement confirms the terms and conditions of your employment by the Company and will constitute your employment agreement. Those terms and co |
|
| December 28, 2009 |
MED BIOGENE INC. COMMON SHARE PURCHASE WARRANT EXHIBIT 4.4 THE WARRANTS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE UNLESS EXERCISED WITHIN THE TIME LIMITS HEREIN PROVIDED. MED BIOGENE INC. COMMON SHARE PURCHASE WARRANT DATED: , 2008 Number of Warrants: Warrant Certificate No.: THIS IS TO CERTIFY THAT, for value received, (the “Holder”) is the registered holder of share purchase warrants (the “Warrants”) of MED BIOGENE INC. (the “Company”) |
|
| December 28, 2009 |
EXHIBIT 4.6 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE , 2009. WITHOUT PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE (“TSXV”) AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF T |
|
| December 28, 2009 |
As filed with the Securities and Exchange Commission on December 28, 2009 Table of Contents As filed with the Securities and Exchange Commission on December 28, 2009 Registration No. |
|
| December 28, 2009 |
MED BIOGENE INC. AGENT?S COMPENSATION OPTIONS CERTIFICATE Form of Warrant issued to agents on August 7 and September 18, 2008 EXHIBIT 4.5 THE OPTIONS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE UNLESS EXERCISED WITHIN THE TIME LIMITS HEREIN PROVIDED. MED BIOGENE INC. AGENT’S COMPENSATION OPTIONS CERTIFICATE DATED: , 2008 Number of Options: Option Certificate No.: THIS IS TO CERTIFY THAT, for value received, (the “Holder”) is the registered holder of |
|
| December 28, 2009 |
ADDITIONAL SPONSORED RESEARCH AGREEMENT Exhibit 10.7 ADDITIONAL SPONSORED RESEARCH AGREEMENT This agreement (this ?Agreement?) is made effective as of the 24th day of February 2009 (the ?Effective Date?) between: UNIVERSITY HEALTH NETWORK an Ontario corporation incorporated by special statute under the University Health Network Act, 1997, having a principal office at 190 Elizabeth Street, R. Fraser Elliott Building - Room 1S-417, Toront |
